IP Library Granted Patent US 11,865,040
Granted Patent B2
US 11,865,040 · App. 17/316,117 · Granted Jan 9, 2024

Vitrectomy cutter

Inventor: Allen Skinner (Chesterfield, MO)
Assignee: Bausch + Lomb Ireland Limited
A61F9/00736
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,865,040
App. No.
17/316,117
Granted
Jan 9, 2024
Kind
B2
Abstract

A vitrectomy system includes a surgical cutting apparatus and a processor. The system includes a cutting assembly with an outer cutter and an inner cutter. The cutting assembly includes a housing containing a drive chamber, a spring chamber, at least a first diaphragm. The first diaphragm is adhered to the inner cutter and positioned between the drive chamber and the spring chamber. The system also includes a drive chamber valve to supply compressed air to the drive chamber and a spring chamber valve to adjust air pressure within the spring chamber. The processor is configured to pulse the drive chamber valve based on a desired cut rate to translate the inner cutter and adjust the air pressure within the spring chamber based on the desired cut rate to adjust the stiffness of the spring chamber.

Claims (26)

1. A vitrectomy system comprising:

a surgical cutting apparatus comprising:

a cutting assembly including an outer cutter and an inner cutter;

a housing coupled to the cutting assembly, the housing containing a drive chamber, a spring chamber, at least a first diaphragm, wherein the at least first diaphragm is adhered to the inner cutter and positioned between the drive chamber and the spring chamber;

a drive chamber valve coupled to the drive chamber to supply compressed air to the drive chamber;

a spring chamber valve coupled to the spring chamber to adjust air pressure within the spring chamber; and

a processor operatively coupled to the surgical cutting apparatus and configured to:

pulse the drive chamber valve based on a desired cut rate to translate the inner cutter at the desired cut rate; and

set and maintain the air pressure in the spring chamber based on the desired cut rate for up to a threshold cut rate and adjust the air pressure within the spring chamber based on the desired cut rate only when the desired cut rate is above the threshold cut rate to adjust the stiffness of the spring chamber.

2. The vitrectomy system of claim 1 , wherein the processor is further configured to increase and maintain the air pressure within the spring chamber via the spring chamber valve when the desired cut rate is increased above the threshold cut rate, and

wherein the processor is further configured to decrease and maintain the air pressure within the spring chamber via the spring chamber valve when the desired cut rate is decreased below the threshold cut rate.

3. The vitrectomy system of claim 1 , wherein the inner cutter is adhered to a second diaphragm.

4. The vitrectomy system of claim 1 , further comprising a pedal coupled to the processor which indicates the desired cut rate to the processor based on the position of the pedal.

5. A vitrectomy system comprising:

a surgical cutting apparatus comprising:

a cutting assembly including an outer cutter cannula and an inner cutter cannula;

a housing coupled to the cutting assembly including a drive chamber and a spring chamber;

a first diaphragm coupled to the housing, wherein the first diaphragm is adhered to the inner cutter cannula and interfaces with the drive chamber and the spring chamber, wherein the spring chamber is defined by the first diaphragm and a wall of the housing, the wall substantially perpendicular to the inner cutter cannula;

a drive chamber valve coupled to the drive chamber to supply compressed air to the drive chamber; and

a spring chamber valve coupled to the spring chamber to adjust air pressure within the spring chamber;

a processor operatively coupled to the surgical cutting apparatus and configured to:

pulse the drive chamber valve based on a desired cut rate to translate the inner cutter at the desired cut rate; and

set and maintain the air pressure in the spring chamber based on the desired cut rate for up to a threshold cut rate and adjust the air pressure within the spring chamber via the spring chamber valve based on the desired cut rate only when the desired cut rate is above the threshold cut rate.

6. The vitrectomy system of claim 5 , wherein the processor is configured to supply the compressed air to the spring chamber when the desired cut rate is increased above the threshold cut rate.

7. The vitrectomy system of claim 5 , wherein the processor is configured to decrease the air pressure within the spring chamber when the desired cut rate is decreased below the threshold cut rate.

8. The vitrectomy system of claim 5 , further comprising a pedal coupled to the processor which indicates the desired cut rate to the processor based on the position of the pedal.

Assignments (12)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (062855/0614) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072486/0705 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY INTEREST Recorded Feb 12, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066552/0041 →
PARTIAL RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 057287/0160) Recorded May 3, 2023
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 063526/0468 →
PARTIAL RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 057821/0800) Recorded May 3, 2023
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 063526/0480 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 24, 2023
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 062855/0614 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 057287/0140) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061776/0836 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
SECURITY INTEREST Recorded Aug 25, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057287/0160 →
SECURITY INTEREST Recorded Aug 25, 2021
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH+LOMB IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 057287/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2021
From: SKINNER, ALLEN
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 056900/0498 →
Continuity (1)
Related Publication 20220354693A1 · Nov 10, 2022